Terri Vidals
Terri Vidals
Healthcare Tech Evolution: Bluesight's Growth and Vision for Diversion Monitoring
Healthcare Tech Evolution: Bluesight's Growth and Vision for Diversion Monitoring
Healthcare Tech Evolution: Bluesight's Growth and Vision for Diversion Monitoring
Tuesday 18th March 2025
Terri Vidals talks with Lauren Forni about Bluesight's strategic growth and future plans for their Control Check diversion monitoring platform.
26 minutes
Informative
Supportive
Educational
Hopeful
Engaging
About this podcast
Author:
Terri Vidals
Overview:
Categories:
Innovative Treatments & Recovery Paths
Nutritional Pathways to Recovery
Family Recovery from Addiction
Navigating Intimate Relationships
Recovery Reimagined
Links:
Visit site
Episodes:
121 (View all)
Do you want to link to this podcast?
Get the buttons here!Bluesight's Vision: Merging Technology for Better Diversion Monitoring
Episode Overview
- Bluesight's strategic acquisitions aim to enhance their diversion monitoring capabilities.
- The integration of Protenus will bring new features to the Control Check platform.
- Optimising workflows is crucial for effective diversion monitoring.
- Community collaboration and knowledge sharing are key to improving healthcare compliance.
- Bluesight is committed to supporting hospitals in preventing drug diversion.
We need to facilitate knowledge and sharing across the industry and how can we best use technology to support that collaboration.
In this episode of 'Drug Diversion Insights with Terri Vidals', we dive into the evolution of healthcare technology and its role in diversion monitoring. Terri Vidals, a seasoned pharmacist, chats with Lauren Forni, Senior Director of Clinical Strategy at Bluesight. Lauren brings a wealth of experience from her background as a pharmacist and her current role at Bluesight, where she helps healthcare facilities optimise their diversion monitoring workflows.
Bluesight has been making significant strides in the healthcare tech space through strategic acquisitions, including their recent purchase of Protenus. Lauren shares how these acquisitions fit into Bluesight's broader vision and their plans for integrating new technologies into their Control Check diversion monitoring platform. You'll get an inside look at how Bluesight is enhancing its offerings to better support hospitals in preventing drug diversion and ensuring regulatory compliance.
The episode also highlights the importance of community collaboration and knowledge sharing in the healthcare industry. By combining expertise and resources from various acquisitions, Bluesight aims to create a more holistic system that benefits all its clients. If you're involved in healthcare and interested in cutting-edge solutions for diversion monitoring, this episode is a must-listen. It offers valuable insights into the future of healthcare compliance and the innovative steps being taken to improve it.